Navigation Links
Consumer Reports Health: Best Drugs for What Ails You, Plus Where to Buy Them for $4 a Month
Date:2/8/2011

YONKERS, N.Y., Feb. 8, 2011 /PRNewswire-USNewswire/ -- A new report in the March issue of Consumer Reports finds that many common generic drugs beat brand names when it comes to safety, efficacy, and cost.  Yet many consumers aren't taking advantage of the discount drug programs offering these drugs at prices as low as $4 a month.  

"Retailers like Kmart, Target, Walgreens, and Walmart have been steadily expanding their discount programs, offering $4 a month prescriptions for drugs that our evidence based program deems 'best buys'," said Lisa Gill, editor, Consumer Reports Best Buy Drugs (BBD).  "We suspect that consumers aren't taking full advantage of these programs because of the constant din of drug advertising which is steering consumers toward overpriced brand name drugs."

Consumer Reports BBD identifies "best buys" based on a review of the medical evidence in partnership with the Drug Effectiveness Review Project (DERP), based at Oregon Health & Science University. For each class of drugs to treat a given condition, Consumer Reports BBD uses an analysis of hundreds of studies — and sometimes thousands — by DERP to derive its "best buy" designations.   The reports, which cover 25 classes of drugs for more than 35 conditions, are available for free at www.ConsumerReportsHealth.org/BestBuyDrugs.

The Best Deal Around: $4 Generics

Drugmakers shell out billions of dollars each year to target consumers with their ads. In 2009, they spent $4.3 billion to reach consumers and $6.6 billion on promotions aimed at doctors, according to IMS Health, which tracks drug sales and marketing.  Drug ads aimed at convincing consumers to ask for a drug by name are working: In a recent poll by Consumer Reports Health, one in five people said they'd asked for a drug they'd seen on TV and most (59 percent) of them said their doctor agreed to write the prescription.

The Best Buy Drugs report explains that generic drug makers must prove that their product contains the identical active ingredients as their brand name counterpart and that the drug is "bioequivalent," meaning that as much active ingredient enters and leaves the bloodstream at the same speed.  The U.S. Food and Drug Administration (FDA) regulates generics just as it does brand-name drugs and monitors them once they're on the market.  To date, the FDA has found no difference in the rate of adverse reactions between generic and brand-name drugs.

"Generics look different from brands because of trademark issues but they're equivalent in efficacy and consumers can save up to 80 percent off the retail price," said John Santa, M.D., M.P.H., director, Consumer Reports Health Ratings Center.  

Some examples of band-name drugs versus low cost generics:

  • High Cholesterol.  Not all cholesterol lowering drugs are the same. Inexpensive generics are the best option unless an individual has had a heart attack or has another heart problem.   Consumer Reports BBD identifies lovastatin (generic) as a "best buy" at $4 a month versus Lipitor at $112 a month.
  • Pain.  For treating moderate pain such as muscle aches or headaches, the best bet may already be in your medicine cabinet. Consumer Reports BBD recommends ibuprofen (generic) for $4 a month versus riskier Celebrex at $139 a month.
  • Depression.  For individuals who need an antidepressant, Consumer Reports BBD recommends five inexpensive generics with which to start treatment.  Compare the recommended fluoxetine (generic) at $4 a month versus heavily advertised Cymbalta for an estimated $181 a month.  Consumer Reports BBD notes that up to 40 percent of people will find no relief with the first antidepressant they try and may need to try a second, different medication or even a third before they find a drug that works for them.

Tips for purchasing $4 generics:

  • Consumers can purchase a 30-day supply for $4 at Target or Walmart without paying a fee.  It's worth considering a 90-day supply for even greater savings per dose.  
  • The following programs require a fee: CVS ($15/year), Kmart ($10/year for one of their programs; another is free), and Walgreens ($20/year for individuals and $35 for the family).  The Costco program is free to Costco members and membership costs $50/year.    
  • Ask about restrictions. Some programs are offered only to people without insurance or are not for medications that are covered by insurance.  And some are not available in certain states or their prices might be higher.
  • Check with your independent pharmacy.  Some will match those deals when possible.
  • Review the discount lists frequently for updates and new additions.  Lipitor and Plavix, two major heart drugs, are likely to become available as a generic over the next 36 months.

MARCH 2011

The material above is intended for legitimate news entities only; it may not be used for advertising or promotional purposes. Consumer Reports® is published by Consumers Union, an expert, independent nonprofit organization whose mission is to work for a fair, just, and safe marketplace for all consumers and to empower consumers to protect themselves.  We accept no advertising and pay for all the products we test. We are not beholden to any commercial interest. Our income is derived from the sale of Consumer Reports®, ConsumerReports.org® and our other publications and information products, services, fees, and noncommercial contributions and grants. Our Ratings and reports are intended solely for the use of our readers. Neither the Ratings nor the reports may be used in advertising or for any other commercial purpose without our permission. Consumers Union will take all steps open to it to prevent commercial use of its materials, its name, or the name of Consumer Reports®.


'/>"/>
SOURCE Consumer Reports
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. The Me-Covery: Saatchi & Saatchi Wellness and Time Inc.s Health Brand Reveal Historic Shift in Female Consumer Behavior
2. CVS Caremark Study Evaluates Which Pharmacy Channel Consumers Choose When Given Choice of Mail or Retail Prescriptions
3. Johnson & Johnson Provides Update on McNeil Consumer Healthcare Remediation; Announces Completion of Internal Assessment Phase of Comprehensive Action Plan
4. FDA Consumer Health Information - New Steps Aimed at Cutting Risks from Acetaminophen
5. Rockbridge Growth Equity Leads Acquisition of Connect America, a Leading Direct to Consumer Provider of Personal Emergency Response Systems (PERS)
6. Important Information for Betaseron® (interferon beta 1-b) Consumers Regarding Triad Groups Alcohol Prep Products
7. Nutrastar to Present at the Cowen and Company 9th Annual Consumer Conference in NYC
8. Hamilton CapTel® and Partner TV Ears to Display Telephone Communication Technology Designed for Individuals with Hearing Loss at Consumer Electronics Show
9. FDA CONSUMER HEALTH INFORMATION - Generic Drug Roundup: December 2010
10. Consumer Reports Health News
11. With Launch of Consumer Product ActiveCare Announces New Head of Sales and Marketing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... , Jan. 19, 2017  Abaxis, Inc. (NasdaqGS: ... point-of-care blood analysis instruments and consumables for the medical ... to discuss its financial results for the third quarter ... will be at 4:15 p.m. ET on Thursday, January ... the third quarter fiscal year 2017 after the market ...
(Date:1/19/2017)... , Jan. 19, 2017  Sensus Healthcare, ... device company specializing in the treatment of non-melanoma ... keloids, with superficial radiation therapy, today announced that ... year 2016 financial results on Thursday, February 2, 2017 ... will hold a conference call with the investment ...
(Date:1/19/2017)... Shire plc (LSE: SHP, NASDAQ: ... and Drug Administration (FDA) has acknowledged receipt of the ... for SHP465, a long-acting, triple-bead, mixed amphetamine salts formulation. ... for Attention-Deficit/Hyperactivity Disorder (ADHD). The FDA is expected to ... the designated Prescription Drug User Fee Act (PDUFA) action ...
Breaking Medicine Technology:
(Date:1/20/2017)... ... 2017 , ... "TransFlare 4K Mystique comes with 44 colorful mysterious transitions that ... Christina Austin - CEO of Pixel Film Studios. , TransFlare 4K Mystique contains ... lens flare and light leak transitions have a very high-dynamic range for super smooth ...
(Date:1/20/2017)... ... January 20, 2017 , ... “The Angel”: a ... has set out for each of his children. “The Angel” is the creation of ... Music in New York City, and impassioned writer. , When asked of her new ...
(Date:1/20/2017)... ... January 20, 2017 , ... D R Burton Healthcare Products ... was featured in a study indicating superior performance against competitive products in secretion ... Three Oscillating Positive Expiratory Pressure Devices During Simulated Breathing“ was published in the ...
(Date:1/20/2017)... ... 2017 , ... “Knowledge is God’s Lighthouse”: a moving and colorful collection ... is the creation of published author, Gene Gaapf, a retired truck driver, and a ... have been writing since high school and have many different titles,” Gaapf mentions about ...
(Date:1/19/2017)... ... 2017 , ... Today, the Centers for Medicare & Medicaid Services (CMS) announced ... Models (APMs) in 2017. Clinicians who participate in APMs are paid for the quality ... the Administration’s effort to build a system that delivers better care and one in ...
Breaking Medicine News(10 mins):